Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up^†

Affiliations

• ¹ Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia, Italy.
• ² State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, People's Republic of China.
• ³ Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, Milan, Italy.
• ⁴ Department of Research, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
• ⁵ Radiation Oncology Clinical Department, National Center for Oncological Hadrontherapy (CNAO), Pavia, Italy.
• ⁶ Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
• ⁷ Department of Otorhinolaryngology Head and Neck Surgery, University Hospital Essen, Essen, Germany.
• ⁸ Sorbonne University, APHP, Department of ENT - Head and Neck Surgery, Tenon Hospital, Paris, France.
• ⁹ Department of ENT - Head and Neck Surgery, Erasmus Medical Center Rotterdam, Rotterdam.
• ¹⁰ Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
• ¹¹ Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
• ¹² Administration Board of Centro Hospitalar e Universitário do Algarve, Portugal.
• ¹³ Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Institut de Recherche Clinique et Expérimentale (POLE MIRO), Université Catholique de Louvain, Brussels, Belgium.